Ectin Research AB (XSAT:ECTIN B) Other Current Liabilities : kr0.80 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Other Current Liabilities?

Ectin Research AB's other current liabilities for the quarter that ended in Mar. 2024 was kr0.80 Mil.

Ectin Research AB's quarterly other current liabilities increased from Sep. 2023 (kr0.68 Mil) to Dec. 2023 (kr0.78 Mil) and increased from Dec. 2023 (kr0.78 Mil) to Mar. 2024 (kr0.80 Mil).

Ectin Research AB's annual other current liabilities increased from Aug. 2020 (kr0.10 Mil) to Dec. 2022 (kr0.87 Mil) but then declined from Dec. 2022 (kr0.87 Mil) to Dec. 2023 (kr0.78 Mil).

Ectin Research AB Other Current Liabilities Historical Data

The historical data trend for Ectin Research AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Other Current Liabilities Chart

Ectin Research AB Annual Data

Trend

Aug19

Aug20

Dec22

Dec23

Other Current Liabilities

Ectin Research AB Quarterly Data
	Aug19	Aug20	Mar21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial								-	-	-	-	-

Ectin Research AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Ectin Research AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB (XSAT:ECTIN B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.ectinresearch.com

Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines